Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Redmond

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
The Chicago Medical Journal|July 6, 2023
A Child without Calvaria or BrainL Redmond
Cross-Reference on Human Resources Management|April 12, 1978
Defining personnel function in multifacility corporationC L Redmond
Expert Opinion on Biological Therapy|August 17, 2023
Challenges and opportunities in the development of combination immunotherapy with OX40 agonistsWilliam L Redmond
Stain Technology|September 1, 1979
A specimen orientation, preview, and mounting device for scanning electron microscopyB L Redmond
Journal of Morphology|October 27, 2018
Observations on the integument of the water mite Arrenurus major (Acari: Parasitengona)B L Redmond
The American Journal of Managed Care|January 26, 2015
Understanding and addressing barriers to recruitmentJennifer L Redmond
Current Opinion in Neurobiology|February 17, 2001
The role of Notch and Rho GTPase signaling in the control of dendritic developmentL Redmond, A Ghosh
Current Oncology Reports|March 30, 2022
Current Clinical Trial Landscape of OX40 AgonistsRashi Yadav, William L Redmond
Immunological Investigations|October 27, 2022
A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral BloodYoshinobu Koguchi, William L Redmond
Oncoimmunology|January 15, 2025
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapyKengo Tanigawa, William L Redmond
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
The Chicago Medical Journal|July 6, 2023
A Child without Calvaria or BrainL Redmond
Cross-Reference on Human Resources Management|April 12, 1978
Defining personnel function in multifacility corporationC L Redmond
Expert Opinion on Biological Therapy|August 17, 2023
Challenges and opportunities in the development of combination immunotherapy with OX40 agonistsWilliam L Redmond
Stain Technology|September 1, 1979
A specimen orientation, preview, and mounting device for scanning electron microscopyB L Redmond
Journal of Morphology|October 27, 2018
Observations on the integument of the water mite Arrenurus major (Acari: Parasitengona)B L Redmond
The American Journal of Managed Care|January 26, 2015
Understanding and addressing barriers to recruitmentJennifer L Redmond
Current Opinion in Neurobiology|February 17, 2001
The role of Notch and Rho GTPase signaling in the control of dendritic developmentL Redmond, A Ghosh
Current Oncology Reports|March 30, 2022
Current Clinical Trial Landscape of OX40 AgonistsRashi Yadav, William L Redmond
Immunological Investigations|October 27, 2022
A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral BloodYoshinobu Koguchi, William L Redmond
Oncoimmunology|January 15, 2025
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapyKengo Tanigawa, William L Redmond
Pageof 21